SCI Pharmtech, Inc. (TPE:4119)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
48.90
-0.65 (-1.31%)
Jul 30, 2026, 12:21 PM CST

SCI Pharmtech Financials Overview

Millions TWD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
1,3591,3441,5241,204899.74864.22
Revenue Growth
-13.65%-11.81%26.54%33.83%4.11%-67.86%
Gross Profit
354.19351.03410.67350.32291.18208.09
Operating Income
154.07155.25198.29160.3118.9773.66
Net Income
95.75107.37534.68294.72308.7855.7
Earnings Per Share
0.800.904.462.692.870.52
EPS Growth
-81.58%-79.86%65.80%-6.27%456.63%-84.53%

Revenue by Geography

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Italy
211.95218.93274.73313.71204.82244.03
Switzerland
113.9675.39130.9671.3854.4652.74
Taiwan
102.62114.62144.9596.23109.3258.52
Germany
137.1599.66100116.08130.4692.76
Netherlands
61.4160.13114.2654.01--
Japan
184.25208.5574.38116.55110.2419.51
United States
189.87212.36128.13127.4793.27108.24
Spain
80.1990.32159.8433.29-30.31
Other Countries
220.11206.04269.2203.67142.26109.32
Belgium
-57.72127.329.94--
Total
1,3591,3441,5241,204899.74864.22

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
52.9674.8692.761,031264.37692.63
Total Debt
1,088987.18990.391,042545.382.16
Net Cash (Debt)
-1,035-912.39-297.63-11.42-281.01690.48
Net Cash Growth
-----9.52%
Net Cash Per Share
-8.64-7.62-2.48-0.10-2.616.42

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
151.63220.32860.52215.77296.57280.28
Capital Expenditures
-463.06-610-946.64-1,029-1,168-771.03
Free Cash Flow
-311.43-389.68-86.12-813.59-871.02-490.75
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
26.06%26.12%26.95%29.09%32.36%24.08%
Operating Margin
11.34%11.55%13.01%13.31%13.22%8.52%
Pretax Margin
6.72%7.61%42.45%30.24%43.10%7.58%
Profit Margin
7.04%7.99%35.09%24.47%34.32%6.44%
FCF Margin
-22.91%-29.00%-5.65%-67.56%-96.81%-56.79%

Dividends

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022
Period EndingJul '26 Dec '25 Dec '24 Dec '23 Dec '22
Dividend Per Share
0.7500.7501.5001.2500.222
Dividend Per Share Growth
-50.00%-50.00%20.00%462.56%-
Dividend Yield
1.50%1.57%1.72%1.36%0.28%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
61.8554.2020.2539.2530.12143.85
Forward PE
-47.2629.3429.3439.4789.36
PS Ratio
4.364.337.119.6110.349.27